// App-Quantinova.ai

: Importance of Immunosuppressive Therapy for Managing Insulin Resistance Type B

Researchers

Presenter

  • Samuel Amankwah

Principal Investigators

  • Artit Silpasuvan

Medical Centers

  • Sinai Hospital of Baltimore, Baltimore, MD

  • Sinai Hospital, Bethesda, MD, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Type 2 diabetes mellitus

  • Dyspnea

  • Diabetes

  • Hyperglycemia

  • Arrhythmia

  • Lupus

Biomarkers

  • C-peptide

  • Hemoglobin A1c

Drug/Treatment

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Prednisone

  • Plaquenil

  • Rituximab

  • Mycophenolate mofetil

  • Diamyd

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved